Table 1
Summary of major results on CKD and ESRD analyzed using healthcare database in Korea

Parameter	Figure	Reference
CKD prevalence in adults	10.6%	[7]
Annual growth rate in number of CKD patients (2006-2010)	8.2%	[8]
Number of treating CKD patients	0.16 million	[9]
Estimated number of treating CKD patients	3.7%	-
CKD as a mortality cause	12/100,000 PY	[6]
Total medical cost of CKD in 2014	KRW1.4 billion	[9]
Annual growth rate in cost of CKD patients (2006-2010)	10.2%	[8]
Ratio of annual medical cost of CKD stage 3, 4, and 5 over that of hypertension	3.0, 4.9, and 21.1	[6]
Crude all-cause mortality rate of ESRD patients	116/1,000 PY	[10]
Overall hazard ratio of PD over HD	1.20	[4]
Hazard ratio of PD survival in 2008 vs. 2005	0.75	[11]
Standard mortality ratio of ESRD patients compared to the general population	10.9	[12]
Total medical cost of HD in 2013	KRW1.6 billion	[13]
Annual growth rate in cost of HD patients (2009-2013)	6.4%	[13]
Ratio of annual medical cost of HD and PD over that of hypertension	86.7 and 65.1	[6]

CKD, chronic kidney disease; ESRD, end-stage renal disease; PY, patient-years; PD, peritoneal dialysis; HD, hemodialysis.